BCBS FEP step therapy denied: how to appeal

Quick answer

If BCBS Federal Employee Program (FEP) denied your step therapy override, you can appeal, and the plan must give you its file and the criteria it used. You have 6 months for carrier reconsideration (FEHB) to file. The date printed on your denial notice controls; it can only be later than these floors, never earlier.

Why BCBS Federal Employee Program (FEP) denies step therapy override

The BCBS Federal Employee Program is the largest carrier in the Federal Employees Health Benefits (FEHB) program. Because FEHB is regulated by the U.S. Office of Personnel Management (OPM), the appeal process bypasses state insurance departments and ends with OPM rather than a state IRO.

For step therapy override specifically: Step therapy (also called 'fail-first') requires patients to try a plan-preferred medication and demonstrate failure or intolerance before the plan will cover the prescribed drug. Federal and many state laws require plans to allow exception requests when the step is clinically inappropriate.

The law that controls this appeal

Federal and state step-therapy override laws require an exception for contraindication, intolerance, prior failure, or likely ineffectiveness.

Note for BCBS Federal Employee Program (FEP): where the standard above cites ERISA or the ACA appeal rules, those describe employer and Marketplace plans. The windows and levels that apply to BCBS Federal Employee Program (FEP) are in the table below.

At a glance

BCBS Federal Employee Program (FEP) appeals: the rule, the deadline and the next level, by plan type

FEHB plans follow federal rules that pre-empt state insurance law. ERISA and state external review do not apply.

Plan type	Rule that governs	File your appeal within	The plan must answer	If the plan says no again
Federal Employees Health Benefits (FEHB) Federal employees, annuitants and their families. The plan brochure is the contract.	5 U.S.C. § 8902 and 5 CFR 890.105 (disputed claims), 890.107 (court review). FEHB law pre-empts state insurance law; ERISA does not apply.	Ask the carrier in writing to reconsider within 6 months of the denial (5 CFR 890.105(a)(1)). If the carrier affirms, ask OPM to review within 90 days of the carrier's reconsideration decision (§ 890.105(e)).	The carrier answers a reconsideration request within 30 days (5 CFR 890.105(c)); OPM's review generally takes up to 60 days once the file is complete (§ 890.105(e)).	OPM disputed-claims review, then suit against OPM in federal court after OPM's final decision (5 CFR 890.107(c)).

Federal Employees Health Benefits (FEHB)

What you can demand. The plan brochure and the carrier's written reconsideration are the record. Ask the carrier for the specific brochure provision and the criteria it relied on.

How to open the appeal. Cite 5 CFR 890.105 and the brochure section at issue: state that the request is a reconsideration under FEHB rules and ask for the criteria and the file.

Primary sources for this table

Windows are federal floors or the rule as written; the denial notice controls. Reviewed 13 September 2026. General information, not legal advice; Apellica is not a law firm.

What BCBS Federal Employee Program (FEP) denies for step therapy override

The step therapy override services most often denied:

Biologics for rheumatoid arthritis, psoriasis, Crohn's, ulcerative colitis
MS disease-modifying therapies
GLP-1s when a less-effective oral is preferred
Newer migraine therapies (CGRP inhibitors)
Specialty oncology when older regimens are preferred

Why step therapy override claims get denied

A typical BCBS Federal Employee Program (FEP) step therapy override denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:

Patient has not tried and failed the preferred drug
Documentation of prior trial / failure is incomplete
Plan does not recognize prior trial done under previous plan
Contraindication or intolerance not documented in record

The BCBS Federal Employee Program (FEP) appeal process

Appeal levels: Internal reconsideration by BCBS FEP, then administrative appeal to OPM, then federal district court under FEHBA.

Carrier timing: Internal reconsideration: typically within 6 months of denial. OPM appeal: within 90 days of final internal denial. Carrier response timeframes mirror ACA standards (30 days standard, 72 hours urgent).

Step therapy timing for BCBS Federal Employee Program (FEP): the filing windows and decision clocks in the table above apply; the date on the notice controls.

What we know about BCBS Federal Employee Program (FEP): FEP appeals require precise citation to the year-specific FEHB brochure. We pull the exact brochure provisions in force on the date of service and brief OPM accordingly.

Common BCBS Federal Employee Program (FEP) denial patterns for step therapy override

OPM is the final reviewer, not the state DOI. After BCBS FEP's internal reconsideration, members appeal to OPM's Healthcare and Insurance office, not to a state external review program. OPM's decision is binding on the carrier and is the prerequisite to any federal-court action.
FEHB brochure controls coverage scope. Every FEHB plan publishes a brochure (the SF-2809-series document) that is the contractually binding statement of benefits for the year. Appeals that quote the brochure language verbatim and contrast it with the denial reason produce a strong record.
Federal court review under FEHBA. After OPM final decision, members may seek judicial review under the Federal Employees Health Benefits Act. The standard of review is generally whether OPM's decision was arbitrary and capricious, so a complete administrative record is essential.

How to win your BCBS Federal Employee Program (FEP) step therapy override appeal

Strategy for step therapy override: File a step-therapy override request citing one of the standard override grounds: (1) prior trial and failure of the preferred drug, (2) contraindication to the preferred drug, (3) intolerance / adverse reaction, (4) likely-ineffective based on clinical characteristics, or (5) stability on current therapy. Attach prior pharmacy records from any plan to demonstrate prior trials. Many state laws now codify a tight response timeline for step-therapy overrides, cite the applicable statute.

Filed against BCBS Federal Employee Program (FEP), that strategy rides on this procedural spine:

Procedural-rights anchor. Cite 5 CFR 890.105 and the brochure section at issue: state that the request is a reconsideration under FEHB rules and ask for the criteria and the file.
Criteria-disclosure demand. BCBS Federal Employee Program (FEP) frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
Controlling-standard citation. Federal and state step-therapy override laws require an exception for contraindication, intolerance, prior failure, or likely ineffectiveness.
Treating-provider attestation. A letter from the treating physician addressing each criterion in BCBS Federal Employee Program (FEP)'s own policy language. This is the single strongest evidentiary element.
Requested action. A specific demand to reverse the step therapy override denial and approve the service, not a general "please reconsider."

Documents you'll need for your BCBS Federal Employee Program (FEP) step therapy override appeal

Denial letter
Prescription record from current and prior plans
Prescriber's letter documenting clinical rationale and any prior trials
Documentation of contraindication or intolerance (if applicable)
Relevant lab values or imaging supporting indication

What a step therapy override appeal can recover

Typical recovery for step therapy override cases runs $500 - $30,000+ per month of medication. The exact figure depends on the specific service and your plan's contracted rates.

BCBS Federal Employee Program (FEP) step therapy override appeals: frequently asked questions

Can I get your BCBS Federal Employee Program (FEP) step therapy requirement waived?

Yes, through a step-therapy override request. Federal and many state laws require plans to grant an exception when the required first-line drug is clinically inappropriate for you.

What are the grounds for a step-therapy override?

Prior trial and failure of the preferred drug, a contraindication to it, an intolerance or adverse reaction, a clinical likelihood that it will be ineffective, or current stability on the prescribed therapy. Any one is sufficient.

How fast must BCBS Federal Employee Program (FEP) respond to an override request?

A standard exception is typically decided within 72 hours and an urgent one within 24 hours. Many state step-therapy laws codify a 72-hour-or-less response requirement.

What if my prior drug trial was under a different plan?

Bring it anyway. Pharmacy records from any prior plan can document a prior trial and failure; plans sometimes refuse to recognize outside trials, but the records are strong evidence on appeal.

What Apellica does for BCBS Federal Employee Program (FEP) step therapy override appeals

We file appeals against BCBS Federal Employee Program (FEP) specifically configured to its internal review process. Every step therapy override appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.

Cost: $0 upfront. We work on contingency for BCBS Federal Employee Program (FEP) appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.

Start your BCBS Federal Employee Program (FEP) step therapy override appeal

Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.

Start free appeal review →

BCBS Federal Employee Program (FEP) denied your step therapy override? Here is what to do next